`_______________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`____________
`
`Case IPR2021-00880
`Patent No. 9,669,069 B2
`_______________
`
`NOTICE OF STIPULATED SCHEDULE
`
`
`
`Case IPR2021-00880
`Patent 9,669,069 B2
`
`Patent Owner, Regeneron Pharmaceuticals, Inc. and Petitioner, Mylan
`
`Pharmaceuticals, Inc. hereby notify the Board that the parties have conferred and
`
`jointly agreed to extending DUE DATE 1, DUE DATE 2, and DUE DATE 3 in the
`
`Joint Scheduling Order (Paper No. 22). In light of Patent Owner’s decision not to
`
`file any motion to amend in this proceeding, the parties stipulate as follows:
`
`DUE DATE 1, originally set for February 2, 2022, is to be reset to February
`
`11, 2022;
`
`DUE DATE 2, originally set for April 27, 2022, is to be reset to May 13,
`
`2022; and
`
`DUE DATE 3, originally set for June 8, 2022, is to be reset to June 24, 2022.
`
`Prior authorization for this Stipulation was provided in the Joint Scheduling Order,
`
`and all other DUE DATES are to remain unchanged.
`
`Dated: December 9, 2021
`
`Respectfully Submitted,
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`3000 El Camino Real #500
`Palo Alto, CA 94304
`
`Counsel for Patent Owner,
`Regeneron Pharmaceuticals, Inc.
`
`1
`
`
`
`Case IPR2021-00880
`Patent 9,669,069 B2
`
`CERTIFICATE OF SERVICE
`The undersigned certifies that a copy of the foregoing NOTICE OF
`
`STIPULATED NOTICE was served on December 9, 2021, via e-mail at the
`
`following email addresses:
`
`MYL_REG_IPR@rmmslegal.com
`paul@ rmmslegal.com
`wrakoczy@ rmmslegal.com
`hsalmen@ rmmslegal.com
`nmclaughlin@rmmslegal.com
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`3000 El Camino Real #500
`Palo Alto, CA 94304
`
`Counsel for Patent Owner,
`Regeneron Pharmaceuticals, Inc.
`
`2
`
`